major depressive disorder

Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Xconomy
Thu, 12/7/17 - 09:18 am
SAGE Therapeutics
major depressive disorder
SAGE-217
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Tue, 08/22/17 - 12:04 am
Alkermes
clinical trials
ALKS 5461
major depressive disorder
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
BioPharma Dive
Thu, 08/3/17 - 10:58 am
23andMe
Lundbeck
genetics
bipolar disorder
major depressive disorder
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Yahoo/24-7 Wall St
Mon, 02/13/17 - 03:32 pm
SAGE Therapeutics
major depressive disorder
SAGE-217
An Early Valuation Of Neuralstem's NSI-189 For MDD
Seeking Alpha
Thu, 06/26/14 - 10:08 am
Neuralstem
NSI-189
major depressive disorder
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Wed, 01/8/14 - 08:37 am
Alkermes
aripiprazole lauroxil
schizophrenia
ALKS 5461
major depressive disorder
Lilly depression drug fails late-stage trial
Yahoo/Reuters
Thu, 12/5/13 - 08:31 am
Eli Lilly
edivoxetine
major depressive disorder
norepinephrine reuptake inhibitors
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Fri, 10/11/13 - 08:53 am
Alkermes
fast track
ALKS 5461
antidepressants
major depressive disorder
Lundbeck, Takeda Win U.S. Approval for Depression Therapy
Bloomberg
Tue, 10/1/13 - 08:49 am
Lundbeck
Takeda
FDA
Brintellix
major depressive disorder
The Next Big Opportunity in Antidepressant Drugs
Motley Fool
Tue, 08/13/13 - 11:08 am
antidepressants
Pfizer
Eli Lilly
Forest Labs
Cymbalta
Fetzima
Pristiq
major depressive disorder
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo
Mon, 04/22/13 - 11:05 am
FDA
Neuralstem
NSI-189
major depressive disorder
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo/AP
Wed, 10/17/12 - 11:54 am
FDA
Neuralstem
NSI-189
major depressive disorder
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
Enhanced Online News
Sat, 09/29/12 - 12:57 pm
levomilnacipran
major depressive disorder
biopolar depression
Forest Labs
Viibryd Launched by Forest Labs
Yahoo/Zacks.com
Thu, 07/7/11 - 11:34 am
Viibryd
Forest Labs
major depressive disorder
Targacept, AstraZeneca begin new trial
Bizjournals.com
Mon, 02/7/11 - 11:21 am
AstraZeneca
Targacept
TC-5214
major depressive disorder
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Seeking Alpha
Tue, 12/14/10 - 11:04 am
FDA
major depressive disorder
Forest Labs
GSK
Eli Lilly
Merck
Clinical Data
Vilazodone
Pfizer
AstraZeneca gets FDA OK for Seroquel XR add-on
Marketwatch
Fri, 12/4/09 - 07:18 am
Seroquel XR
AstraZeneca
major depressive disorder

Pages